TrialOncoimmunology2021

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine.

Elisabeth S Stovgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.